ENGIPORE
PRE-FORMED BONE SUBSTITUTE
Engineered for orthopaedic surgery
Various shapes for each bone grafting need Micro, Macro and interconnected porosity (up to 90%) leads to:
- higher integration rates
- Optimal compromise between osteointegration and mechanical performance
- Provides long-lasting osseous integration
Ideal biomimetic architecture
ENGIpore is an innovative porous hydroxyapatite biomaterial with a trabecular structure similar to that of natural bone.
It is a ready available bone graft, manufactured to a highly controlled specification and free of disease transmission risk.
Different shapes have been designed to provide surgeons with a full range of products to meet their bone grafting needs.
Rapid Osteointegration
Once applied in situ, ENGIpore rapidly absorbs all bio-active proteins, growth factors and bone precursor cells contained in the physiological fluids. This encourages and begins the biological cascade leading to effective bone regeneration.
Micro, macro and interconnected porosity
This biomaterial has a unique, controlled micro and macro porosity along with an effective structure that supports rapid bone ingrowth and formation.
Its unique structure gives ENGIpore a porosity of almost 90%, and this guarantees an easy access of cells, biological fluids, and attracting the correct molecules throughout the bone substitute.
Despite the highly porous structure, ENGIpore is able to resist the compression forces associated with natural bone.
Its unique structure gives ENGIpore a porosity of almost 90%, and this guarantees an easy access of cells, biological fluids, and attracting the correct molecules throughout the bone substitute.
Despite the highly porous structure, ENGIpore is able to resist the compression forces associated with natural bone.
Computer simulation of vascular ingrowth
MACROporosity
Trabecular Structure
MICROporosity
Clinical Applications
- Proximal Humerus Fracture
- Metacarpal Fracture
- Open Wedge Osteotomy



ENGIpore is not intended to modify or replace standard procedures for the treatment of bone defects, but for filling bony voids or gaps of the skeletal system, that are not intrinsic to the stability of the bony structure.